Telomere length and cardiovascular disease risk
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Telomere length has been hypothesized as a putative biomarker for cardiovascular disease. However, the findings are mixed and shared confounding factors may explain these associations. The current review aims to summarize the recent literature on the role of telomere length in cardiovascular disease and give directions for future potential as a predictive biomarker. RECENT FINDINGS: In this review, we outline the biology of telomeres as a biomarker of aging through its shortening capacity across the life course. Recent epidemiological evidence for its associations with cardiovascular risk factors and disease is discussed. Then we highlight the possible causal role of telomeres in coronary heart disease and summarize the potential biological mechanisms and pathways known. SUMMARY: The current research and results presented on telomere length may implicate that short telomeres are causal risk factors for cardiovascular disease, partially through insulin-mediated pathways. Nevertheless, further studies with refined quantification methods and larger populations are needed to clarify the added role of telomere length in predicting future risks of cardiovascular disease on top of existing risk biomarkers, and whether it may be amenable for intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596 · cited 2×
“Instead, the telomeres get shorter across the human lifespan and has ever since they were discovered in the mid 80s been considered as a biomarker of aging [1,2].”
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
Haycock, P. C., Heydon, E. E., Kaptoge, S., Butterworth, A. S., Thompson, A., & Willeit, P. (2014) · BMJ · doi:10.1136/bmj.g4227 · Cited by 856
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Fitzpatrick, A. L., Kronmal, R. A., Gardner, J. P., Psaty, B. M., Jenny, N. S., Tracy, R. P., Walston, J., Kimura, M., & Aviv, A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj346 · Cited by 773
Telomeres shorten at equivalent rates in somatic tissues of adults
Daniali, L., Benetos, A., Susser, E., Kark, J. D., Labat, C., Kimura, M., Desai, K. K., Granick, M., & Aviv, A. (2013) · Nature Communications · doi:10.1038/ncomms2602 · Cited by 601 · cited 1×
“2019 Wolters Kluwer H yet correlated, may present longer average telomere lengths than leukocytes [7,8].”
Gomes, N. M. V., Ryder, O. A., Houck, M. L., Charter, S. J., Walker, W., Forsyth, N. R., Austad, S. N., Venditti, C., Pagel, M., Shay, J. W., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00718.x · Cited by 464 · cited 1×
“The telomeric function is preserved across many species and was first discovered in Tetrahymena thermophile and yeast [2] but are present also in zebrafish [14], birds [15] and mammals [16].”
Mechanisms and consequences of macrophage apoptosis in atherosclerosis
Seimon, T., & Tabas, I. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800032-jlr200 · Cited by 411
Cited by
Vaiserman, A., & Krasnienkov, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.630186 · Cited by 454
“Low telomerase activity and short LTLs were shown to be associated with atherosclerotic plaque instability and higher risk for coronary heart disease, myocardial infarction or stroke (Yeh andWang, 2016; Tian et al., 2019; Zhan and Hägg, 2019).”
BackgroundTelomeres as Therapeutic Targets in Heart Disease
Yeh, J.-K., Lin, M.-H., & Wang, C.-Y. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.009 · Cited by 49
Fazzini, F., Lamina, C., Raschenberger, J., Schultheiss, U. T., Kotsis, F., Schönherr, S., Weissensteiner, H., Forer, L., Steinbrenner, I., Meiselbach, H., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.02.034 · Cited by 38
“This finding provides possible support for a potential causal role of RTL in CVD.45,46 Furthermore, cellular senescence induced by telomere attrition could be a trigger of atherosclerosis as well arteriosclerosis.”
BackgroundLejawa, M., Osadnik, K., Osadnik, T., & Pawlas, N. (2021) · Antioxidants · doi:10.3390/antiox10010093 · Cited by 30
Immune senescence in multiple myeloma—a role for mitochondrial dysfunction?
Seymour, F., Carmichael, J., Taylor, C., Parrish, C., & Cook, G. (2022) · Leukemia · doi:10.1038/s41375-022-01653-7 · Cited by 11
“Telomere shortening is a key feature of cellular senescence and accelerated telomere shortening is a common feature of agerelated diseases including Alzheimer’s disease [18], osteoarthritis [19], and cardiovascular disease [20].”
Background
Metadata
- Authors
- Zhan, Y., & Hägg, S.
- Venue
- Current Opinion in Cardiology
- Published
- 2019-05
- Volume
- 34
- Issue
- 3
- Pages
- 270-274
- ISSN
- 0268-4705 (ISSN-L)
- OpenAlex
- W2921707030
- Cited by
- 57
- References
- 16
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomere length and cardiovascular disease risk. https://app.cochat.ai/papers/10.1097/hco.0000000000000613
- The paper
- Zhan, Y., & Hägg, S. (2019). Telomere length and cardiovascular disease risk. Current Opinion in Cardiology. https://doi.org/10.1097/hco.0000000000000613
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.